HUT63563A - Process for producing encapsulated pharmaceutical composition comprising alkali hidrogen carbonate active ingredient - Google Patents

Process for producing encapsulated pharmaceutical composition comprising alkali hidrogen carbonate active ingredient

Info

Publication number
HUT63563A
HUT63563A HU383291A HU383291A HUT63563A HU T63563 A HUT63563 A HU T63563A HU 383291 A HU383291 A HU 383291A HU 383291 A HU383291 A HU 383291A HU T63563 A HUT63563 A HU T63563A
Authority
HU
Hungary
Prior art keywords
alkali
hidrogen
pharmaceutical composition
active ingredient
producing encapsulated
Prior art date
Application number
HU383291A
Other languages
Hungarian (hu)
Other versions
HU913832D0 (en
Inventor
Gyoergy Csermely
Tibor Galambos
Gyoergy Jancso
Istvan Kovacs
Zoltan Kovacs
Janos Petervari
Original Assignee
Multikemia Vegyianyagokat Eloe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multikemia Vegyianyagokat Eloe filed Critical Multikemia Vegyianyagokat Eloe
Priority to HU383291A priority Critical patent/HUT63563A/en
Publication of HU913832D0 publication Critical patent/HU913832D0/en
Publication of HUT63563A publication Critical patent/HUT63563A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical prepn. for treatment of duodenal ulcer, contains 50-150 mg. pref. 100 mg. formulated alkali-hydrogen-carbonate.
HU383291A 1991-12-06 1991-12-06 Process for producing encapsulated pharmaceutical composition comprising alkali hidrogen carbonate active ingredient HUT63563A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU383291A HUT63563A (en) 1991-12-06 1991-12-06 Process for producing encapsulated pharmaceutical composition comprising alkali hidrogen carbonate active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU383291A HUT63563A (en) 1991-12-06 1991-12-06 Process for producing encapsulated pharmaceutical composition comprising alkali hidrogen carbonate active ingredient

Publications (2)

Publication Number Publication Date
HU913832D0 HU913832D0 (en) 1992-02-28
HUT63563A true HUT63563A (en) 1993-09-28

Family

ID=10965696

Family Applications (1)

Application Number Title Priority Date Filing Date
HU383291A HUT63563A (en) 1991-12-06 1991-12-06 Process for producing encapsulated pharmaceutical composition comprising alkali hidrogen carbonate active ingredient

Country Status (1)

Country Link
HU (1) HUT63563A (en)

Also Published As

Publication number Publication date
HU913832D0 (en) 1992-02-28

Similar Documents

Publication Publication Date Title
HU9201548D0 (en) Process for the production of a medical composition
AU8229691A (en) Starch encapsulation of biologically active agents by a continuous process
NO171787C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 8-AZABICYCLO (3.2.1) OCT-2-ONE COMPOUNDS
AU3592389A (en) Therapeutic product
HUT60430A (en) Process for producing medical aerosol compositions
HUT53514A (en) Process for producing granulates suitable for peroral compositions with controlled, repeated release of active ingredient
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
HUT58058A (en) Insecticidal composition and process for producing its active ingredient, 1-phenylimidazole derivatives
HUT50092A (en) Process for producing 1,3-glycols from epoxides
CA2093282A1 (en) Intraoral medicament-releasing device
HU9203322D0 (en) Method for producing cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diine derivatives
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
HUT48231A (en) Process for producing 2-phenylbenzoxepin derivatives and pharmaceutical compositions comprising such compounds
NZ232946A (en) Preparation of crystalline 17alpha-hydroxy-7alpha methyl-19-nor-17-pregn-5
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
EP0311385A3 (en) Optically active hydroxybenzylamine derivative, optically active amine-boron compound containing said derivative, and process for producing optically active compound by using said compound
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
HU905725D0 (en) Process for producing 1,4-disubstituted 5-aryl-carbamoyl-4(6)-oxo-6(4)-oxido-pyrimidine-betaine derivatives and anthelmintic preparatives containing these compounds as active substance
HUT63563A (en) Process for producing encapsulated pharmaceutical composition comprising alkali hidrogen carbonate active ingredient
HUT63462A (en) Process for producing new glycopeptides and pharmaceutical compositions comprising same as active ingredient
HU913520D0 (en) Process for the production of 7-acyl-3(substituted carbamoiloxy)-cefem-derivatives and of the medical preparations containing them
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
HUT58337A (en) Process for producing pharmaceutically active benzopyranopyrazols
HUT63956A (en) Process for producing tablets comprising dirithromycin
EP0623323A3 (en) Process for preparing a medical implant.

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee